15-Year Followup of a Population Based Prostate Cancer Screening Study

Journal of Urology

Volumn 181, Issue 4, 2009, Pages 1615-1621

  Kjellman, Anders ^a   Akre, Olof ^a,b   Norming, Ulf ^a   Törnblom, Magnus ^a   Gustafsson, Ove ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Center for Oncologic Prevention   (Italy)

Author keywords

mass screening; mortality; outcome assessment (health care); prostate; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; DEATH; DIGITAL RECTAL EXAMINATION; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; OVERALL SURVIVAL; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION;

AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATIC NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 62049084446     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.11.115     Document Type: Article

References (17)

1. de Koning H.J., Auvinen A., Berenguer Sanchez A., Calais daSilva F., Ciatto S., Denis L., et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 97 (2002) 237
2. Pinsky P.F., Miller A., Kramer B.S., Church T., Reding D., Prorok P., et al. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol 165 (2007) 874
3. Gustafsson O., Norming U., Almgard L.E., Fredriksson A., Gustavsson G., Harvig B., et al. Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 men. J Urol 148 (1992) 1827
4. Beisland H.O. Neodymium-YAG laser in the treatment of localized prostate cancer. Ann Chir Gynaecol 79 (1990) 200
5. Helgesson O., Bengtsson C., Lapidus L., Merck C., and Sparen P. Malignant disease observed in a cohort of women. A validation of Swedish Cancer Registry data. Scand J Soc Med 22 (1994) 46
6. Mattsson B., and Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23 (1984) 305
7. Kjellman A., Akre O., Norming U., Tornblom M., and Gustafsson O. Dihydrotestosterone levels and survival in screening-detected prostate cancer: a 15-yr follow-up study. Eur Urol 53 (2007) 106
8. Ilic D., O'Connor D., Green S., and Wilt T. Screening for prostate cancer: a Cochrane systematic review. Cancer Causes Control 18 (2007) 279
9. Labrie F., Candas B., Dupont A., Cusan L., Gomez J.L., Suburu R.E., et al. Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial. Prostate 38 (1999) 83
10. Sandblom G., Varenhorst E., Lofman O., Rosell J., and Carlsson P. Clinical Consequences of screening for prostate cancer: 15 years follow-up of a randomised controlled trial in Sweden. Eur Urol 46 (2004) 717
11. Postma R., Schroder F.H., van Leenders G.J., Hoedemaeker R.F., Vis A.N., Roobol M.J., et al. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Section Rotterdam. A comparison of two rounds of screening. Eur Urol 52 (2007) 89
12. Hugosson J., Aus G., Lilja H., Lodding P., and Pihl C.G. Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma. Cancer 100 (2004) 1397
13. Roobol M.J., Grenabo A., Schroder F.H., and Hugosson J. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam. J Natl Cancer Inst 99 (2007) 1296
14. Tornblom M., Eriksson H., Franzen S., Gustafsson O., Lilja H., Norming U., et al. Lead time associated with screening for prostate cancer. Int J Cancer 108 (2004) 122
15. Zackrisson S., Andersson I., Manjer J., and Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 108 (2004) 754
16. Zackrisson S., Lindstrom M., Moghaddassi M., Andersson I., and Janzon L. Social predictors of non-attendance in an urban mammographic screening programme: a multilevel analysis. Scand J Public Health 1 (2007) 7
17. Lagerlund M., Maxwell A.E., Bastani R., Thurfjell E., Ekbom A., and Lambe M. Sociodemographic predictors of non-attendance at invitational mammography screening-a population-based register study (Sweden). Cancer Causes Control 13 (2002) 73